Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
13.03
-0.34 (-2.54%)
At close: Mar 3, 2026, 4:00 PM EST
13.03
0.00 (0.00%)
After-hours: Mar 3, 2026, 4:38 PM EST
Orthofix Medical Stock Forecast
Stock Price Forecast
The 4 analysts that cover Orthofix Medical stock have a consensus rating of "Buy" and an average price target of $18.25, which forecasts a 40.06% increase in the stock price over the next year. The lowest target is $14 and the highest is $22.
Price Target: $18.25 (+40.06%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Orthofix Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $24 → $20 | Strong Buy | Maintains | $24 → $20 | +53.49% | Feb 26, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +30.47% | Feb 25, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $18 | Buy | Maintains | $18 | +38.14% | Feb 17, 2026 |
| TD Cowen | TD Cowen | Hold Initiates $14 | Hold | Initiates | $14 | +7.44% | Jan 27, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $17 → $18 | Buy | Maintains | $17 → $18 | +38.14% | Nov 5, 2025 |
Financial Forecast
Revenue This Year
880.01M
from 822.31M
Increased by 7.02%
Revenue Next Year
934.74M
from 880.01M
Increased by 6.22%
EPS This Year
-2.32
from -2.33
EPS Next Year
-1.58
from -2.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 917.6M | 980.1M | |||
| Avg | 880.0M | 934.7M | |||
| Low | 837.7M | 883.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.6% | 11.4% | |||
| Avg | 7.0% | 6.2% | |||
| Low | 1.9% | 0.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|
| High | -2.38 | -1.63 | ||
| Avg | -2.32 | -1.58 | ||
| Low | -2.22 | -1.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.